Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cushing Syndrome × Dabigatran × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Venous Thromboembolism 4 Neoplasms 4 Venous Thrombosis 3 Pulmonary Embolism 2 Thrombosis 1 Prostatic Neoplasms 1 Myeloproliferative Disorders 1 Embolism 1 Cushing Syndrome 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

relacorilant 5 Mifepristone 3 Corlux 3 Osilodrostat 2 Metyrapone 2 Adrenalectomy 2 pembrolizumab 1 Observation 1 Dabigatran 1 Continuous Glucose Monitoring 1 Abiraterone Acetate 1 ASP3662 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05347979 2023-02-09

Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-glycoprotein Substrate Dabigatran Etexilate in Healthy Participants

Corcept Therapeutics

Phase 1 Completed

Cushing Syndrome, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡